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Research suggests that current heroin users and individuals with a prior history of
heroin dependence tend to be more aggressive than nonusers. No study has yet
investigated whether opioid withdrawal affects aggressive responses on a laboratory
task. The present study investigates whether mild opioid withdrawal affects aggression
in six males and six females (N=12) undergoing methadone maintenance
therapy. Aggressive behavior is measured using the Point Subtraction Aggression
Paradigm (Cherek, 1981) computer task. Participants press buttons to earn money
towards gift certificates. Money subtractions occur periodically and these are attributed to
the behavior of a partner who is actually fictitious. Participants respond to protect their
earnings or respond to protect their earnings while also subtracting money from the
partner (the aggressive response option). Behavior on the PSAP is measured on two
separate days; once prior to and once following the participant’s daily methadone
dose. There are no differences in rates of aggressive responding on the PSAP or in selfreports of mood across conditions. These data suggest that the opioid deprivation
occurring 24-hrs following methadone administration in individuals undergoing MMT
does not produce heightened aggression, at least on this task in these generally nonviolent participants.
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INTRODUCTION
Heroin addiction is associated with a variety of harmful and maladaptive behavior
patterns. For example, heroin addiction has been linked to antisocial behaviors and social
deviance (Fieldman, Woolfolk, & Allen, 1995), aggression (Gerra, Zaimovic, Moi,
Bussandri, Bubici, Mossini, Raggi, & Brambilla, 2004; Gerra, Zaimovic, Raggi, Guisti,
Delsignore, Bertacca, & Brambilla, 2001; Gerra, Zaimovic, Raggi, Moi, Branchi,
Moroni, & Brambilla, 2007), anger and hostility (Steer & Schut, 1981), Antisocial
Personality Disorder, and engaging in illegal and reckless behaviors (Darke, Hall, &
Swift, 1994). A meta-analysis of 14 studies concluded that there is a strong positive
association between heroin use and criminal activity (Bennett, Holloway, & Farrington,
2008). Heroin use is also strongly associated with violent and aggressive crimes. A study
investigating violent offences determined that 81% of 160 heroin addicts interviewed had
been the offender in a violent crime, and most of them had been involved in multiple
violent incidents during their lives (Darke, Torok, Kaye, Ross, & McKetin, 2010).
Heroin use and addiction is therefore a major public health and safety concern.
Four explanations have been offered as to why violence may occur in substance
abusers, 1) violence occurs to obtain the drug of abuse, 2) violence occurs to resolve
disputes related to the drug which cannot be resolved in a legal manner, 3) violent
behavior may be related to some trait associated with drug abuse, or 4) drug effects may
increase the probability of violent acts (Hoaken & Stewart, 2003). Some studies indicate
that the relationship between aggressive responding and opioid use may be the result of
personality factors (Gerra et al., 2001). Alternatively, some studies have shown that
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acute administration of opioids directly increases aggression (Berman, Taylor & Marged,
1993; Spiga, Cherek, Roache & Cowan, 1990).
Laboratory Measures of Aggression
Most studies investigating the relationship between opioid use and aggression or
violence are field studies and the data have been correlational (e.g., Fieldman, Woolfolk,
& Allen, 1995; Steer and Schut, 1981). Thus, laboratory studies are needed to better
assess the relationship between opioid use and aggression. Directly studying aggressive
behavior in the laboratory is difficult, however, because aggressive responses occur only
infrequently. As a result, many laboratory studies on aggression have used self-reports of
aggression or aggressive tendencies, such as the Buss–Durkee hostility scale (Buss &
Durkee, 1957), the Overt Aggression Scale (Yudofsky, Silver, Jackson, Endicott, &
Williams, 1986), or the updated Buss–Perry Aggression Questionnaire (Buss & Perry,
1992).
Other researchers, however, have sought to develop more direct measures of
aggressive behavior (Buss, 1961; Cherek, 1981; Taylor, 1967). In order to study
aggressive behavior directly in the laboratory, it is necessary to develop an operational
definition of aggression. That is, the behavior must be clearly defined, easily measurable,
and observable. Most laboratory studies have operationally defined aggressive behavior
as responding that results in the presentation of an aversive stimulus (e.g., electric shock
or money loss) to another individual (Buss, 1961; Cherek, 1981; Taylor, 1967).
Defining aggressive behavior in terms of its topography contrasts with typical response
definitions in operant psychology that define behavior units in terms of the relationship
between behavior and environmental variables. From an operant psychology perspective,
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it is not sufficient to define aggression based solely upon response topography. A
relationship must exist between an antecedent, a behavior, and a particular consequence
for a behavior to be labeled as ‘aggressive.’ Cahoon (1972) lists several antecedent
situations (e.g., aversive stimulation, discriminative stimuli associated with
reinforcement, extinction, stimuli that signal the removal of positive reinforcers) and
consequences (e.g., removal of aversive stimuli, presentation of positive reinforcers) that
may maintain aggressive behaviors. Laboratory studies have shown that responses
defined as aggressive do vary as a function of changes in antecedent and consequent
variables, and therefore are functional units (Cherek, 1981; Cherek, Spiga, Bennett, &
Grabowski, 1991). Aggression that is ‘accidental’ is distinguished from operant behavior
maintained by particular consequences by its very low frequency of recurrence, as well as
a low frequency of alternate aggressive behaviors in the individual’s repertoire that result
in the same consequence (Cahoon, 1972).
In laboratory aggression tasks, aggressive behavior is often provoked by
delivering an aversive stimulus to the participant. For example, several laboratory tasks,
including the ‘teacher-learner’ paradigm (Buss, 1961) and the Taylor Competitive
Reaction Time Task (Taylor, 1967), ask participants to administer a painful shock to a
confederate in order to study the frequency, intensity, and duration of shocks
administered under various experimental conditions. Aggressive behavior in these
studies is defined as responding that results in the delivery of a harmful or aversive
stimulus (shock) to another individual. To provoke aggression in the Taylor Competitive
Reaction Time task, the participant receives shocks that increase incrementally in
intensity which are attributed to the behavior of the partner (confederate). Aggressive
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responding is instigated in the ‘teacher-learner’ paradigm by asking participants to
administer a shock contingent upon a wrong answer from the ‘learner’.
Although the Buss and Taylor tasks have provided useful assessments of
aggression (Buss, 1961; Taylor, 1967), they have some limitations. First, these tasks do
not provide a nonaggressive response alternative. Including a nonaggressive option is
important so that (a) responding on the nonaggressive option can serve as a control for
any changes in responding on the aggressive option, and (b) the aggressive response
option is not the only response option available to participants. Second, in these tasks
measures of aggressive responding (i.e., magnitude or duration of shock delivery) can
only vary across a limited range and therefore may not be sensitive to some experimental
manipulations.
Another laboratory task developed to study aggression is the Point Subtraction
Aggression Paradigm (PSAP; Cherek, 1981). This task includes a nonaggressive
response alternative and it allows aggressive responding to vary across a wide range.
During the PSAP, participants are provoked with presentations of money losses which
are attributed to the behavior of a fictitious partner. Participants are presented with three
choice options. One option produces money. The second option ostensibly subtracts
money from a partner’s earnings (the aggressive response) and initiates a temporary
timeout from subtractions by the partner. The third option also initiates a temporary
timeout from subtractions (the escape response). On this task, aggression is measured by
the frequency of responding on the aggressive response option. Aggression on this task
is therefore defined as responding to present an aversive stimulus (money loss) to another
individual. Males (Cherek, Moeller, Schnapp, & Dougherty, 1997) and females (Cherek,

5

Lane, Dougherty, Moeller, & White, 2000) with violent criminal histories, individuals
with Antisocial Personality Disorder (Moeller, Dougherty, Lane, Steinberg, & Cherek,
1998), and people with Borderline Personality Disorder with comorbid Intermittent
Explosive Disorder (New, Hazlett, Newmark, Zhang, Triebwasser, & Meyerson, 2009)
tend to show more aggressive responses than matched controls on the PSAP, thereby
supporting the validity of the task as a measure of aggressive behavior. Although
responding on the PSAP is typically assessed across multiple sessions (e.g., Cherek,
1981), the PSAP also can be an effective method of assessing individual differences in
aggression when administered for only a single session (Golomb, Cortez-Perez, Jaworski,
Mednick, & Dimsdale, 2007).
Because aggressive responses in laboratory aggression tasks occur following
provocations, these tasks measure rates of reactive aggression. Reactive aggression is
defined as a defensive response in retaliation for a provocation that was perceived as
having hostile intent (Dodge & Coie, 1987). The PSAP, however, also allows an
assessment of proactive aggression. Proactive aggression is defined as an aggressive
response that occurs prior to any provocations (Dodge & Coie, 1987). Proactive
aggression can be measured on the PSAP by recording the number of aggressive
responses that occur prior to the first money subtraction per session. Reactive aggression
can be measured by recording the number of aggressive responses that occur after money
subtractions have been presented.
Opioids and Laboratory Measures of Aggression
The PSAP has been used to assess aggressive responding in substance abusers.
Individuals who reported drug-use histories scored higher on the PSAP and on
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psychometric measures of aggression than those without such histories (Allen, Moeller,
Rhoades, Cherek, 1997). Studies have also shown that individuals who were previously
addicted to heroin made more aggressive responses than control subjects on the PSAP
task and scored higher on psychometric measures of aggression and irritability (Gerra et
al., 2001; Gerra et al., 2004; Gerra et al., 2007). This was true whether participants were
currently being treated with methadone or buprenorphine (Gerra et al., 2001; Gerra et al.,
2007), or were abstinent without pharmacological treatment (Gerra et al., 2004).
Individuals who were previously addicted to heroin also exhibited fewer monetaryreinforced responses when they were abstinent, compared to nonusers (Gerra et al., 2004)
and when they were on methadone maintenance therapy (Gerra et al., 2001). The lower
rate of responding on the monetary-reinforced option during abstinence or treatment may
indicate either a decrease in motivational levels or decreased attention.
Two studies with humans have shown that the acute administration of opiates can
increase levels of aggression in laboratory aggression tasks. Berman, Taylor and Marged
(1993) showed that morphine increased the likelihood that an individual would deliver
more intense and more frequent shocks to a confederate on the Taylor Aggression Task,
whereas Spiga, Cherek, Roache and Cowan (1990) showed that codeine increased
aggressive responses on a version of the PSAP that did not have an escape response.
These findings are consistent with the results of several studies with rats that have also
shown that acute opioid administration increases aggression (Haney, Mczek, 1989;
Espert, Navarro, Salvador, & Simon, 1993).
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Methadone
Methadone is a synthetic opioid agonist which binds to and activates opioid
receptors (Ward, Hall, & Mattick, 2009). It is used as an opioid replacement in a
treatment known as methadone maintenance therapy (MMT). This treatment involves
replacing heroin use with methadone dispensed by a medical clinic. Methadone allows
the patient to stop using heroin without experiencing sudden opioid withdrawal.
Methadone is much safer than heroin because medical personnel ensure that the correct
dose is taken each time, and the medication is guaranteed to be the same mixture and
potency each time the person receives it. Methadone has the ability to reduce cravings
for heroin, and to block feelings of euphoria if heroin is subsequently used (Ward, Hall,
& Mattick, 2009). Methadone has an elimination half life of approximately 24-36 hrs
(Ward, Hall, & Mattick, 2009), which is much longer than the 3-6 hr elimination half-life
of heroin. Thus, unlike heroin, which must be injected every few hours to maintain
steady blood levels, methadone is typically taken orally once per day. Absorption into
the blood stream occurs at a slow rate with orally ingested methadone, and therefore does
not produce the same intoxication and euphoria that results from heroin use. Methadone
exerts dose-dependent effects. That is, higher doses are more effective than lower doses
in reducing illicit opioid use (e.g., Donny, Walsh, Bigelow, Eissenberg, & Stitzer, 2002;
Greenwald, 2002), reducing withdrawal symptoms and craving, and retaining patients in
treatment (Veilleux, Colvin, Anderson, York, & Heinz, 2010). The typical methadone
maintenance dose prescribed ranges from 50-150 mg per day (Veilleux et al., 2010).
A recent review of the pharmacological properties of methadone notes that onset
of effect occurs within 30 min of administration, and the highest blood levels of
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methadone occur within 2-4 hrs (Gordon, Hitchinson, La Vincente, Mitchell, Morrish,
Newcombe, Somogyi, & White, 2009). Blood levels peak and then decrease from 4 hrs
after administration until the next dose is given. The pharmacologic effect of methadone
varies over the 24-hr dosing period, and is correlated with changes in blood
concentrations of the drug. As blood concentrations decrease, withdrawal symptoms
appear and become more severe. Severe withdrawal typically occurs 36-48 hrs after the
last dose has been administered, and may last from 5 to 21 days.
Methadone maintenance has been shown to benefit individuals addicted to heroin
by reducing many risky behaviors such as sharing needles, overdosing, and engaging in
illegal behaviors (Ward, Hall & Mattick, 2009). Criminal behavior has been shown to
decrease after methadone maintenance treatment (Simoens, Ludbrook, Matheson, &
Bond, 2006), but it is unknown whether the decrease in criminal activity is a
pharmacological effect of the drug, or if it is an effect of a change in lifestyle and living
environment during treatment (Gossop, Marsden, Stewart, & Rolfe, 2000; Löbmann, &
Verthein, 2009). No laboratory studies thus far have investigated the acute effects of
methadone administration on aggressive behavior.
Opioid Withdrawal and Aggressive Behavior
It is important to study the effects of withdrawal from opioid drugs on aggression
to determine whether aggressive responding is likely to increase during abstinence or
when drug levels decrease. Several studies have investigated the effects of opioid
deprivation on aggressive behavior. These studies have found that during withdrawal,
participants show enhanced aggression and changes in mood. For example, participants
in detoxification often display increased aggression and irritability, as shown by
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subjective effects questionnaires and objective behavioral observations (e.g., Bickel,
Stitzer, Liebson & Bigelow, 1988; Gerra, Zaimovic, Rustichelli, Fontanesi, Zambelli,
Timpano, Bocchi, & Delsignore, 2000).
The effects of drug abstinence on aggression may be interpreted from an operant
psychology perspective by assuming that drug deprivation functions as a motivational
operation. A motivational operation is an event that alters the probability of certain
behaviors by changing the reinforcing or punishing value of environmental stimuli
(Michael, 1982). Drug deprivation may act as a motivational operation which affects the
reinforcing potency of stimuli produced by acts of aggression. Alternatively, drug
deprivation may make punishing events such as money loss more aversive.
No study has investigated the effects of opioid withdrawal on aggressive behavior
using a laboratory aggression task. This may be because exposing individuals addicted to
opioids to acute opioid withdrawal raises ethical concerns given the health risks and
discomfort produced by withdrawal. During MMT, however, individuals regularly
experience mild withdrawal prior to taking their daily methadone (see below). Thus,
MMT may be a useful model for investigating the effects of opioid deprivation on
aggression.
Methadone Withdrawal
Several studies suggest that mild to moderate levels of deprivation occur 24-hrs
following methadone administration. For example, several studies have shown that blood
levels of methadone peaked 2-3 hrs after administration, and decreased until the
following dose was administered (Dyer, Foster, White, Somogyi, Menelaou, & Bochner,
1999; Hanna, Foster, Salter, Somogyi, White, & Bochner, 2005; Hiltunen, Beck,
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Hjemdahl, Liljeberg, Almstrom, Brodin, Wachtenfeldt, & Borg, 1999). Objective
physical signs of withdrawal and subjective participant ratings of withdrawal were lowest
during peak blood levels, and increased as blood levels decreased. Dyer et al., (1999)
reported that physiological effects of methadone, including pupil dilation, increased pain
threshold, and subjective feelings, only lasted up to 8 hrs after administration.
Behavioral effects of methadone, including signs of withdrawal, are also affected
by the passage of time since the last dose (Dyer et al., 1999; Hanna et al., 2005; Hiltunen
et al., 1999;). For example Dyer et al., (2001) found significant changes in mood
associated with the passage of time over the 24-hr dosing interval including increased
anger, depression, tension, confusion, and fatigue, as measured by the Profile of Mood
States (POMS) questionnaire. Furthermore, the presentation of a laboratory stressor
(consisting of a 3000 Hz tone played at 90 dB for 10 min while the participant attempted
to solve an unsolvable computer task) was shown to cause stronger cravings when
administered just prior to dosing compared to just after the dose was given (Ilgen, Jain,
Kim, & Trafton, 2008).
Several studies have found no withdrawal effects during methadone maintenance
therapy. For example, McMillan and Gilmore-Thomas (1996) found no changes in self
reported craving levels and Torrens, Castillo, San, del Mmoral, Gonzalez, and de la Torre
(1998) found no changes in self-reports of physical withdrawal symptoms in individuals
currently on MMT. However, these studies only collected self-reports (i.e., questionnaire
data) rather than direct measures of behavior. More objective measures may provide a
more accurate assessment of withdrawal.
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Overall, the results of the studies described above suggest that at the end of the
24-hr dosing cycle, methadone maintenance patients may experience mild withdrawal
and therefore may exhibit heightened aggression. To this author’s knowledge, no field
studies have reported increases in aggressive behavior in methadone patients near the end
of the end of the 24-hr dosing cycle. Nonetheless, the possibility remains that
participants on MMT experience heighted aggressive tendencies that go unreported.
Investigating the effects of opioid withdrawal on aggressive behavior in patients
undergoing methadone maintenance therapy may provide additional data on the
effectiveness of a 24-hr dosing regimen in minimizing withdrawal symptoms.
Purpose
The present study investigated aggressive behavior in patients receiving
methadone as part of opioid replacement therapy to determine if there were changes in
aggressive behavior across opioid deprived and non-deprived states. Specifically,
performance on a laboratory aggression task, the PSAP, was measured just prior to and
just after patients received their daily methadone dose on separate days. Changes in
responding on the aggressive, escape-maintained, and monetary-reinforced responses on
the PSAP task were compared across the two time periods. Rates of responding prior to
and following provocations on the PSAP were also analyzed to determine whether
methadone deprivation selectively affected proactive or reactive aggression.
Because the findings from studies investigating the effects of methadone
deprivation on mood have been mixed (e.g., Dyer et al., 2001; Hiltunen et al., 1999;
McMillan & Gilmore-Thomas, 1996), in the present study changes in mood were also
assessed using a self-report mood questionnaire, the Profile of Mood States (POMS;
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McNair & Droppleman, 1971). Ratings of mood were measured prior to completing the
PSAP after methadone administration (during drug satiation), and after 24-hr methadone
deprivation. Mood ratings were also collected after completing the PSAP on both
deprivation and satiation days to evaluate the effects of the task on mood, and any
interaction between completing the task and deprivation condition.
METHODS
Participants
All methods were approved by the Human Subjects Internal Review Board at
Western Michigan University. Twelve adults (six females and six males) ages 25 to 52
(average 36) years currently on methadone maintenance therapy with a history of opioid
dependence participated. Participants were recruited by hanging flyers in lobbies of
methadone maintenance clinics in Southwest Michigan. The flyers advertised a study on
decision making and sought volunteers. Potential participants contacted experimenters
by phone and were given a brief description of what participating involved. If the person
was interested in participating, the experimenter scheduled an appointment to complete
the informed consent process. After informed consent was obtained, participants filled
out a brief subject information form. Participants were recruited into the study if they
reported having no visual or auditory impairments that would prevent them from
completing the computer task, reported not taking any psychiatric medications other than
methadone, reported drinking fewer than 14 alcoholic drinks per week, and were able to
read and understand the instructions. No participants were excluded from the study due
to these criteria. Overall, 17 participants were recruited and completed the informed
consent process and of these 12 completed the study. One participant reported being
intoxicated after signing the informed consent document and failed to reschedule
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sessions. One participant informed disclosed to the researchers after her second day of
participation that she had taken her methadone dose prior to the session on both days, and
her data were therefore excluded from the analysis. Three participants failed to complete
the second day of participation. Of the twelve participants who completed the study, nine
were Caucasian (75%), two were Hispanic (16.67%), and one was American Indian
(8.33%). Length in methadone maintenance treatment ranged from 2 weeks to 9 yrs (M=
3.08, SD= 2.8). Drug use histories are shown in Table 1.

Table 1. Mean (with standard deviation in parentheses) years of drug use and percent of
participants that reported using each drug.
Drug

Average

% of Participants

Prescription Narcotics (Including Opioids) 14.58 (±11.56) yrs 100% (12/12)
Heroin

5.38 (±5.32) yrs

67% (8/12)

Illicit Methadone

2.17 (±2.94) yrs

58.33% (7/12)

Morphine

5.2 (±6.11) yrs

58.33% (7/12)

Cocaine

8.85 (±9.45) yrs

83% (10/12)

Marijuana

12.7 (±9.8) yrs

92% (11/12)

Crack

4.63 (±9.32) yrs

50% (5/10)

Apparatus
Sessions were conducted in conference rooms in two methadone clinics. Curtains
were used to create a 0.37 square meter cubicle. The cubicle contained a small table with
a PC laptop computer, a chair, and a computer mouse. The laptop computer recorded and
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controlled experimental sessions. Pink noise was generated and played through an
individual speaker in each cubicle space. Pink noise varied between 20 Hz to 20,000 Hz.
Procedure
Individuals were asked to participate on three different days. On the first two
days of participation, subjects came to a private room inside the clinic. Prior to the first
session, subjects completed the POMS questionnaire. They also completed a recent drug
use questionnaire to determine when the last dose of methadone was taken.
Participants completed three experimental (PSAP) sessions per day on the first
two days (six sessions total). Each experimental session lasted 25 min, followed by a 5min break. After completing all experimental sessions each day, participants completed a
post-experiment questionnaire to evaluate the effectiveness of the social deception
(whether they believed they were working with a partner), and completed the POMS
questionnaire again. All participants believed they were paired with others each day and
thus all data were included in the analysis.
On the third day of participation, participants were asked to complete the BussPerry aggression questionnaire which assessed lifetime aggressive tendencies (Buss &
Perry, 1992). After participants completed this questionnaire, they were paid their
completion bonus, and were partially debriefed. All earnings were paid in gift
certificates to Meijer or Wal-Mart, depending on the preference of the participant. Full
debriefing (i.e., information about the social deception) occurred when all participants
had completed the study using a debriefing phone script (see Appendix). A diagram of
the daily schedule for participants on each day of participation is shown in Tables 2-4.
Note that not all participants began sessions at 9:00 am.
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Table 2. Day 1 Daily Schedule Example
9:00 am

Check in & complete POMS

9:10 am

Task Instructions

9:15 am

PSAP Task Session 1

9:40 am

5 min Break

9:45 am

PSAP Task Session 2

10:10 am

5 min Break

10:15 am

PSAP Task Session 3

10:40 am

Deception Questionnaire and complete POMS

10:50 am

Payment in gift certificates and release

Table 3. Day 2 Daily Schedule Example
9:00 am

Check in & complete POMS

9:10 am

PSAP Task Session 1

9:35 am

5 min Break

9:40 am

PSAP Task Session 2

10:05 am

5 min Break

10:10 am

PSAP Task Session 3

10:35 am

Deception Questionnaire and complete POMS

10:45 am

Payment in gift certificates and release
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Table 4. Day 3 Daily Schedule Example
9:00 am

Check in and complete Buss-Perry

9:05 am

Payment in gift certificates (including completion bonus)
and debriefing

9:15 am

Release

Design
The experiment used a repeated-measures design. The PSAP task was
administered the first time to half of the participants just prior to receiving their daily
methadone dose (n=6). This was approximately 24-hrs after having received their last
methadone administration, and was therefore a time at which the participant was
expected to experience withdrawal. The task was administered the first time to the other
participants approximately 30 min after receiving their methadone dose (n=6). Because
peak effects of methadone occur 120 min after administration, we expected peak effect of
methadone administration to occur during the last experimental session. The second day
that participants completed the PSAP, those who completed it prior to receiving
methadone took it after, and vice versa. This counterbalancing of methadone
administration (before vs. after the PSAP) was designed to control for effects of repeated
exposure to the PSAP task.
Point Subtraction Aggression Paradigm
The PSAP task required responding on a computer mouse to stimuli on the
computer screen. A counter located at the top of the screen showed total earnings. At the
start of the session, the counter was set to $0.00. The earnings counter never went into
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the negative. At the start of each session, and in the absence of responding, the
participant experienced a variable time schedule of money subtractions with intervals
ranging from 6 s to 120 s. These subtractions were attributed to the behavior of the
fictitious partner. The participant chose between three response options. The three
options were designated on the computer screen with three letters; A, B, and C (left to
right, approximately 50.8 mm in height). To choose an option, the participant had to
move the mouse pointer over the letter and make a mouse click. Each response produced
a brief flashing of the letter. Once a response was made on one of the buttons, the other
letters disappeared until the response requirement was completed on the selected option.
The first option, Button A (monetary-reinforced option), required that the participant emit
100 mouse clicks to earn money (15¢). Button B was the aggressive response option.
The participant was told that if they made 10 mouse clicks on the B option then 15¢
would be subtracted from the counter of their partner. Completing the response
requirement on option B also produced a timeout from the schedule of money
subtractions for a variable time period averaging 125 s (participants were not told about
this contingency). The third option, Button C, was an escape option. Ten mouse clicks
on option C produced a timeout from the schedule of money subtractions for a variable
time period averaging 125 s. One subtraction was required to occur before responses on
button C or B initiated the provocation-free period. This ensured that the number of
subtractions could be reduced but not completely avoided. Responses on Button B were
considered aggressive, because the participant was told that this would result in monetary
loss to another participant. In reality, the other participant was fictitious.
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Instructions
At the start of each session, participants were given instructions about the computer task.
The instructions read:
Today, you will be able to earn money by working at the computer task. You will
be participating with another person in this study. These other people will have
similar computer tasks. These other people are located at another facility. Three
buttons will appear on the screen labeled A, B and C. When each session starts,
the letters A, B and C and a counter will appear on the computer screen. The
counter will be at zero. Pushing the A button will cause the B and C letter to go
off the screen. Pushing the A button approximately 100 times will cause the A
letter to go off the screen, and add 15¢ to the counter. After about 1 s, the A, B
and C letters will come back on the computer screen. At that time, you can
continue to press button A or switch to button B or C. During the session the
counter on your computer screen may become larger and 15¢ will be subtracted.
After the 15¢ is subtracted, the counter will return to its normal size. This means
that one of the other persons has subtracted 15¢ from your counter by pushing
button B on his response panel. The money that this person subtracts from your
counter is added to his counter. If you push button B on your response panel, the
A and C letters will go off the screen. After you have pushed button B
approximately 10 times, the letter B will go off the screen and 15¢ will be
subtracted from the other person’s counter. After about 1 s, the A, B and C letters
will come back on the computer screen. You can continue to press button B and
subtract additional money from the other person or switch to button A or C. If you
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subtract money from the other person, it will not be added to your counter.
Remember, money subtracted from your counter by the other person is added to
that person’s counter. If you push button C on your response panel, the A and B
letters will go off the screen. After you have pushed button C approximately 10
times, the letter C will go off the screen and your earnings displayed on the
counter will be protected from subtractions initiated by the other person for some
period. After about 1 s, the A, B and C letters will come back on the computer
screen. You can continue to press button C or switch to button A or B.
The participant was then asked if he or she had any questions. If so, the relevant portion
of the instructions was re-read to the participant. On the second day of participation the
participant was asked if they remembered the instructions or wanted them to be re-read.
All participants reported remembering the instructions and did not request another
reading.
Earnings
Participants were paid $8 per hr to compensate them for time spent completing
questionnaires, listening to the instructions, and being partially debriefed, which took
approximately 1 hr total during the entire study. Participants also earned money during
experimental sessions. Earnings during sessions varied as a function of performance, but
averaged around $8-10 per hr. In the event that a participant’s total earnings by the end
of the study equaled less than a mean of $8.00 per hr of participation, the participant was
compensated accordingly (i.e., paid an additional amount) so that the total earnings
averaged $8 per hr that the subject participated. Seven participants required this
additional payment. Participants were paid at the end of the last daily session the amount
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earned during each of the three sessions that day. At the end of the study, participants
who completed all scheduled sessions were also given a completion bonus of $10.
Participants who quit the study early forfeited the completion bonus. All payments were
made in the form of gift cards, which were rounded up to the nearest $5.
Data Analysis
Data were analyzed using non-parametric statistics, including the Wilcoxon
Matched-Pairs Signed Rank and the Friedman test. To compensate for the increased
potential for Type I error associated with multiple comparisons, the significance level
was set at .01.
RESULTS
PSAP Responding
The primary dependent measures on the PSAP were aggressive, escape, and
monetary-reinforced responses per session. Figure 1 shows mean responses summed
across all three sessions on the PSAP on the three response options during the drug
deprivation and drug satiation conditions. Rates of responding on all measures were
similar across conditions. A Wilcoxon Matched-Pairs Signed Rank test showed no
significant effect of deprivation condition on any of the three response options (mean
monetary-reinforced responses pre versus post dose, p=.64; mean aggressive responses
pre versus post dose, p=.94; mean escape responses pre versus post dose, p=.78). The
same analysis showed no significant effect of deprivation condition on responses when
only response rates from the last session of each day were compared (Session 3
monetary-reinforced responses pre versus post dose, p=.05; Session 3 aggressive
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Figure 1. Mean and standard deviation of aggressive, escape, and monetary-reinforced
responses on the PSAP compared on deprivation day and satiation day.

responses pre versus post dose, p=.62; Session 3 escape responses pre versus post dose,
p=.82). Figure 2 shows monetary-reinforced, escape, and aggressive responses as a
function of session across the 6 consecutive experimental sessions for participants
exposed to both deprivation/satiation and satiation/deprivation condition sequences. A
Friedman test revealed a significant increase in monetary-reinforced responses between
the first session and the last session (p=.003), and a significant decrease in escape
responses between the first session and the last session (p=.006). There were no
significant changes in aggressive responding (p=.69).
An analysis of daily cumulative records of aggressive responses showed that all
aggression that occurred was reactive aggression, as no participant made an aggressive
response prior to a money loss provocation.
POMS
Overall, there were 6 missing values for Profile of Mood State (POMS)
questionnaire data, out of 3,835. For these analyses, missing questionnaire data were
handled as follows: The mean of the scores for that participant in that mood category was
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Figure 2. Mean and standard deviation of monetary-reinforced, escape, and aggressive responses on the
PSAP across the 6 total sessions.

used to replace the missing value. Measures on the POMS questionnaire were compared
across deprivation and satiation states prior to completing the PSAP to assess effects of
deprivation on mood independent of task completion. Figure 3 shows deprivation day
versus satiation day reports on the POMS when administered prior to the PSAP
aggression task. Ratings on the POMS were also compared pre and post PSAP task on
deprivation and satiation days to evaluate the effects of completing the task on mood
under both conditions. Figures 4 and 5 show responses on the POMS questionnaire
before and after the PSAP aggression task on both satiation and deprivation days,
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Figure 3. Mean and standard deviation of responses on the Profile of Mood States (POMS) taken prior
to the Point Subtraction Aggression Paradigm (PSAP) task on deprivation day and satiation day.
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Figure 4. Mean and standard deviation of responses on the Profile of Mood States (POMS) taken on
drug satiation day prior to and after completing the Point Subtraction Aggression Paradigm (PSAP)
task.
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Figure 5. Mean and standard deviation of responses on the Profile of Mood States (POMS) taken
on drug deprivation day prior to and after completing the Point Subtraction Aggression Paradigm
(PSAP) task.

respectively. Mood on the POMS questionnaire was not affected by methadone
condition or the PSAP task. A Friedman test revealed no significant differences between
the composite mood scores when compared prior to and after the computer task on both
deprivation and satiation day.
Correlations
Length in methadone maintenance treatment was not significantly correlated with
aggressive responses on the PSAP (during either condition) or other psychometric
measures of aggression. A Pearson correlation revealed no significant relationship
between length in treatment and aggression on the PSAP, POMS, or Buss-Perry. The
three aggression scores were not significantly correlated with each other: A Pearson
correlation revealed no significant correlation between aggressive responses on the
PSAP, reports of anger on the POMS, or trait aggression measured by the Buss-Perry.

25

Lastly, there were no significant gender differences on measures of aggression on the
POMS, PSAP, or Buss-Perry.
DISCUSSION
The goal of the present study was to investigate the effects of mild opioid
deprivation on aggressive responding during a laboratory choice task in patients currently
undergoing opioid (methadone) replacement therapy. Specifically, performance on a
laboratory aggression task, the Point Subtraction Aggression Paradigm (PSAP), was
measured on two separate occasions, once just prior to and once just after patients
received their daily methadone dose. Changes in responding on the aggressive, escapemaintained, and monetary-reinforced responses on the PSAP task were compared across
the two time periods.
The study found that mild opioid deprivation associated with the 24-hr dosing
interval used in methadone maintenance therapy was not associated with a statistically
significant change in monetary-reinforced, aggressive, or escape responding on the
PSAP. One possible reason for the similarity in behavior across deprivation and satiation
conditions is that the deprivation experienced during MMT within the 24-hr dosing
interval may not have been severe enough to influence levels of aggressive responding on
the PSAP task, or self-reported anger, tension, or hostility. Several previous studies also
have found no self-reported withdrawal effects during the typical daily methadone cycle
(McMillan & Gilmore-Thomas, 1996; Torrens et al., 1998). Thus, these data may be
interpreted as showing that the 24-hr dosing interval currently used in methadone
maintenance therapy is adequate in preventing withdrawal severe enough to induce
behavioral changes, at least on this task in this population.
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Another possible explanation for the lack of effect of methadone deprivation on
aggressive responding is that the participants in this study were generally non-violent and
therefore unlikely to show much aggressive responding. Average aggressive responses
on the PSAP were lower than those of methadone maintenance patients in previous
studies (e.g., Gerra et al., 2001; Gerra et al., 2004; Gerra et al., 2007). The average
aggressive responses made by the current participants across 3 sessions were 175.6 on
deprivation day, and 193.4 on satiation day. These rates of aggressive responding are
much lower than those made by participants in prior studies who were previously
addicted to heroin and currently on methadone (Gerra et al., 2001; Gerra et al., 2007),
buprenorphine (Gerra et al., 2007), or who had been abstinent from all opioid use for
several years (Gerra et al., 2004), all of whom had mean rates of above 300 per 25 min
session. In fact, aggressive responding of participants in the current study on the PSAP
was similar to responding by the control subjects used in previous studies that were not
previous opioid users (Gerra et al., 2001; Gerra et al., 2004; Gerra et al., 2007), which
had average aggressive response rates of slightly over 100 per 25 min session.
Approximately 20% of the participants in Gerra et al. (2007) had psychiatric symptoms
of Antisocial Personality Disorder (ASPD). Individuals with this disorder tend to score
higher on the PSAP than controls (Moeller et al., 1998; Moeller, Dougherty, Rustin,
Swann, Allen, Shah, & Cherek, 1997). The present study did not directly assess whether
participants had a history of ASPD (although no participants reported having any
psychiatric diagnoses), making comparisons to the Gerra et al. (2007) study difficult.
Nonetheless, it seems likely that the participants in the present study were less aggressive
than the participants in the Gerra et al. (2007) study. Future research could compare
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deprivation in individuals with or without ASPD to determine whether a history of
aggressive responding contributes to heightened aggressive behavior under opioid
withdrawal on the PSAP.
Exposure to the PSAP
Monetary-reinforced responses increased as a function of exposure to the task.
This finding indicates that performance on the task improved with practice and
participants learned to maximized the amount of money earned. Alternatively, escape
responses decreased as a function of exposure to the task across the 6 sessions. The
decrease in escape responding might have occurred because escape responding was
inefficient in the first few sessions. In the first few sessions, participants pressed the
escape option much more frequently than once per provocation. Recall that each escape
response produced a variable-time 120s provocation-free period, and that one
provocation was required before additional escape responses were effective. Thus,
additional escape responses within that provocation-free period offered no additional
protection from money losses. As participants gained additional exposure to the task,
they emitted fewer escape responses, and allocated more responding to the monetaryreinforced option. Aggressive responding was not affected by exposure to the task and
was similar across the 6 sessions. It is unclear why aggressive responding did not show
the same decrease across sessions as escape responding.
Proactive aggression (aggressive responses prior to a money loss provocation) did
not occur in any session for any participant during this experiment. All aggression was
reactive aggression, in that it occurred after the first money-loss provocation of the
session. This indicates that aggressive responses occurred in retaliation for the money
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loss that was attributed to the fictitious partner. If drug deprivation acted as a motivating
operation (MO) which made aggression reinforcers more potent, proactive aggression
would be expected to increase. On the other hand, if drug deprivation made money-loss
provocations from others more aversive, reactive aggression would be expected to
increase, as individuals would be more likely to retaliate against opponents in order to
avoid money losses (negative reinforcement). The lack of change in aggressive
responding from satiation to deprivation states suggests that drug deprivation did not act
as an MO to alter the potency of either aggression reinforcers or money loss.
Prior research has shown that opioid use tends to decrease cognitive-motor
performance, and psychomotor speed (Mintzer & Stitzer, 2002; Specka, Finkbeiner,
Lodemann, Leifert, Kluwig, & Gastpar, 2000). Despite this, there was no effect of
methadone satiation or deprivation on monetary-reinforced responses. This may indicate
that acute methadone administration does not affect motor responding, at least as
assessed by mouse clicks on the PSAP task. One previous study using push buttons also
found that monetary-reinforced responses on the PSAP were not affected by acute
administration of an opioid (codeine) (Spiga, Cherek, Roache & Cowan, 1990).
POMS Findings
Mild methadone deprivation did not affect participant’s self reported mood. This
finding is consistent with two previous studies which also found no change in withdrawal
symptoms or craving associated with the mild opioid withdrawal related to MMT
(McMillan & Gilmore-Thomas,1996; Torrens et al., 1998). Contrary to this, several prior
studies have found that the mild withdrawal associated with the 24-hr dosing interval of
methadone maintenance therapy leads to higher tension, anger, and irritability on self-
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report measures (Dyer et al., 2001) as well as objective and subjective signs of
withdrawal (Hanna et al., 2005; Hiltunen et al., 1999). One possible explanation for the
discrepant results is that in the above studies approximately half of the participants were
non-holders, meaning that they complained of withdrawal symptoms and were unhappy
with their current dosing level. This may have contributed to the fluctuations in mood
and withdrawal symptoms that were observed during the methadone dosing interval. It is
also possible that participants who showed no changes in mood, such as in the present
study, may have had less violent histories. As described above, participants with violent
histories tend to respond more aggressively on the PSAP and other measures of
aggression (Moeller et al., 1998; Moeller et al., 1997). Unfortunately, it is impossible to
determine definitively whether participants in prior studies were more aggressive overall
because prior studies either did not take data on aggressive behavioral traits (e.g., Dyer et
al., 2001), or they did not separate irritability/aggression from other negative withdrawal
symptoms (e.g. Hiltunen et al., 1999). The average anger score on the POMS in the
current study (14.96 on deprivation day, 14.30 on satiation day) is comparable to the
lowest anger scores in methadone maintenance patients in prior research, but unlike
previous research, anger scores in the present study did not increase as time from the last
dose increased (Dyer et al., 2001). When the Dyer et al. scores were adjusted to account
for the different Likert scale, the anger score on the POMS averaged approximately 14
two hours after methadone administration, and increased to an average of 18 twenty-two
hrs later. The low anger scores in the current study support the hypothesis that the
participants in the current study may have been a particularly nonaggressive sample.
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Correlations
Aggression on the PSAP was not significantly correlated with aggression on the
Buss-Perry or the POMS. Prior studies have correlated PSAP aggression scores with the
Buss-Perry Aggression Questionnaire and also found no relationship between this
psychometric measure and laboratory behavioral measure of aggression, although the
lack of effect was attributed to small sample size (e.g., Dougherty, Bjork, Marsh, &
Moeller, 1999; Lieving, Cherek, Lane, Tcheremissine, & Nouvion, 2008; Tcheremissine,
Lane, Lieving, Rhoades, Nouvion, & Cherek, 2005). That the measures are not
correlated may not be surprising, however, given that the Buss-Perry measures lifetime
aggressive traits, whereas the POMS measures current mood state, and the PSAP
measures the frequency with which an individual will actually make an aggressive
response against others.
Length in methadone treatment also was not significantly correlated with
aggression scores on the PSAP, POMS, or Buss-Perry. Prior research has found that
individuals on methadone maintenance treatment show significant mood disturbance
compared to healthy controls (Dyer et al., 2001). Based on this, one would assume that
length on methadone maintenance therapy may be associated with increased aggression.
It has been suggested that this increase in aggression may be a result of tolerance to the
positive effect that opioids have on mood (White, 2004). Tolerance to opioids often
causes a drug-opposite effect. For example, acute opioid administration causes increased
pain threshold, pupil constriction, and decreased respiration (Dyer et al., 1999). With
prolonged exposure to opioids, tolerance to these effects develops and individuals
experience a drug-opposite effect where they chronically experience a lower pain
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threshold, pupil dilation, and increased respiration. White (2004) proposed a compelling
theory that the increase in positive mood experienced with acute administration of
opioids may also be subject to the same drug-opposite effects with tolerance. This is
supported by the increased mood disturbance seen in opioid users compared to healthy
controls (Dyer et al., 2001). Contrary to this, the current study did not provide
compelling evidence that length in treatment significantly affects mood or aggression.
Finally, gender was not correlated with aggression on any of the measures,
indicating that being male or female did not make individuals more or less likely to
behave aggressively on this task. Several meta-analyses of laboratory measures of
aggression have shown that gender differences are inconsistent in the literature, but that
generally males tend to display slightly more direct aggression (e.g., causing physical
harm or name-calling), and that both males and females tend to display similar amounts
of indirect aggression (e.g., spreading rumors or gossiping; Card, Stucky, Sawalani, &
Little, 2008; Eagly & Steffen, 1986). Based on the inconsistency of gender differences in
the previous literature it is not surprising that we did not see a significant difference in
aggressive behavior between males and females in the current study.
Limitations
There were several limitations to the current study. One is that the withdrawal
generated by 24-hr methadone deprivation was mild. MMT is designed to prevent the
withdrawal that occurs while discontinuing heroin use. Although previous studies have
shown that mood is influenced by the mild state of deprivation that occurs during MMT,
this deprivation may not have been severe enough to affect behavior on an operant task.
Moreover, this deprivation did not affect mood in the current study. Perhaps if
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participants had abstained from methadone for a period longer than 24-hrs, this more
severe deprivation would have had an effect on their behavior.
Another limitation of this study is the somewhat small sample size (N=12). As
noted above, levels of aggressive responding in participants were generally low. It is
possible that different effects may be seen in another population. Some studies have
shown that drug effects differ in individuals with more aggressive histories (Bailly, &
King, 2006; Cherek, Lane, Pietras, Sharon, & Steinberg, 2002)
Future Research
There are several potential directions for future studies to investigate the effects of
opioid deprivation on aggression. First, as noted above, the PSAP could be used to
determine whether the mild opioid deprivation associated with methadone maintenance
has a greater effect on aggressive behavior in individuals with a more violent history. It
may be possible to recruit participants with more violent histories by recruiting
individuals with Antisocial Personality Disorder, or by using a self-report screener such
as the Life History of Aggression assessment (Coccaro, Berman, & Kavoussi, 1997) to
select individuals with violent pasts. Future studies could also investigate the effects of
more severe opioid deprivation, which may be more likely to lead to a change in
aggressive behavior. Although there may be serious ethical concerns with inducing
opioid withdrawal for the sake of experimentation, it may be possible to study behavior
in a population that is already experiencing withdrawal for the purposes of treatment. For
example, it may be possible to measure aggressive behavior in individuals undergoing
heroin detoxification, or in individuals initiating treatment of an opioid antagonist, such
as buprenorphine. It is important to know whether these procedures may lead to an
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increased probability of aggressive behavior. Lastly, it may be necessary to use an
animal model to investigate the relationship between more severe opioid deprivation and
aggression. Previous research on opioid withdrawal in animals has shown mixed results.
One study in primates found no change in the aggressive behaviors of primates towards
another primate following opioid deprivation (Fabre-Nys, Meller, & Keverne, 1982).
Conversely, other studies have found that morphine withdrawal markedly increased
aggression in rats (Felip, Rodríguez-Arias, Espejo, Miñarro, & Stinus, 2000; Tidey, &
Miczek, 1992). Due to these conflicting results, future research is needed to investigate
whether opioid withdrawal precipitates aggressive behavior.
Summary
In summary, the mild opioid deprivation associated with methadone maintenance
therapy did not produce an increase in aggressive responding. This supports the clinical
prescription of methadone as an opioid treatment. Specifically, it suggests that the 24-hr
dosing period may not produce deprivation that is severe enough to induce potentially
problematic aggressive behavior. Additional research needs to be completed to
determine whether aggressive responding is likely to increase during more prolonged
opioid abstinence.
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